Burger MK, Schaller DJ. Metabolic Acidosis. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].
Hamm LL, Nakhoul N, Hering-Smith KS. Acid-Base Homeostasis. Clin J Am Soc Nephrol. 2015 Dec 7. 10 (12):2232-42. [QxMD MEDLINE Link].
Reddy P, Mooradian AD. Clinical utility of anion gap in deciphering acid-base disorders. Int J Clin Pract. 2009 Oct. 63(10):1516-25. [QxMD MEDLINE Link].
Noritomi DT, Soriano FG, Kellum JA, et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care Med. 2009 Oct. 37(10):2733-9. [QxMD MEDLINE Link].
Rastegar M, Nagami GT. Non-Anion Gap Metabolic Acidosis: A Clinical Approach to Evaluation. Am J Kidney Dis. 2017 Feb. 69 (2):296-301. [QxMD MEDLINE Link].
Türe H, Keskin Ö, Çakır Ü, Aykut Bingöl C, Türe U. The frequency and severity of metabolic acidosis related to topiramate. J Int Med Res. 2016 Oct 26. [QxMD MEDLINE Link].
Patschan D, Patschan S, Ritter O. Chronic Metabolic Acidosis in Chronic Kidney Disease. Kidney Blood Press Res. 2020 Dec 2. 1-11. [QxMD MEDLINE Link]. [Full Text].
DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016 Feb. 65 (2):20-9. [QxMD MEDLINE Link].
Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol. 2014 Jan. 9 (1):191-200. [QxMD MEDLINE Link]. [Full Text].
Mehta AN, Emmett JB, Emmett M. GOLD MARK: an anion gap mnemonic for the 21st century. Lancet. 2008 Sep 13. 372(9642):892. [QxMD MEDLINE Link].
Yousaf A, Malik B, Abdelazeem B, Kunadi A. Emergent Hemodialysis Followed by Continuous Renal Replacement Therapy: A Management Challenge in a Patient With Life-Threatening Metabolic Acidosis of Multifactorial Etiology. Cureus. 2022 Mar. 14 (3):e23689. [QxMD MEDLINE Link]. [Full Text].
Hermez K, Dudash-Mion C. Profound Metabolic Acidosis due to Metformin Intoxication Requiring Dialysis. Case Rep Nephrol. 2021. 2021:9914982. [QxMD MEDLINE Link]. [Full Text].
Maciel AT, Park M. Differences in acid-base behavior between intensive care unit survivors and nonsurvivors using both a physicochemical and a standard base excess approach: a prospective, observational study. J Crit Care. 2009 Dec. 24(4):477-83. [QxMD MEDLINE Link].
Morimatsu H, Toda Y, Egi M, et al. Acid-base variables in patients with acute kidney injury requiring peritoneal dialysis in the pediatric cardiac care unit. J Anesth. 2009. 23(3):334-40. [QxMD MEDLINE Link].
Walsh SB, Shirley DG, Wrong OM, Unwin RJ. Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: an alternative to ammonium chloride. Kidney Int. 2007 Jun. 71(12):1310-6. [QxMD MEDLINE Link].
Pereira PC, Miranda DM, Oliveira EA, Silva AC. Molecular pathophysiology of renal tubular acidosis. Curr Genomics. 2009 Mar. 10(1):51-9. [QxMD MEDLINE Link]. [Full Text].
Seheult J, Fitzpatrick G, Boran G. Lactic acidosis: an update. Clin Chem Lab Med. 2017 Mar 1. 55 (3):322-333. [QxMD MEDLINE Link]. [Full Text].
Starke A, Corsenca A, Kohler T, Knubben J, Kraenzlin M, Uebelhart D, et al. Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality. Clin J Am Soc Nephrol. 2012 Sep. 7(9):1461-72. [QxMD MEDLINE Link]. [Full Text].
Harris AN, Grimm PR, Lee HW, Delpire E, Fang L, Verlander JW, et al. Mechanism of Hyperkalemia-Induced Metabolic Acidosis. J Am Soc Nephrol. 2018 May. 29 (5):1411-1425. [QxMD MEDLINE Link].
Dubey AK, Sahoo J, Vairappan B, Haridasan S, Parameswaran S, Priyamvada PS. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial. Nephrol Dial Transplant. 2018 Jul 24. [QxMD MEDLINE Link].
Kendrick J, Shah P, Andrews E, You Z, Nowak K, Pasch A, et al. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study. Clin J Am Soc Nephrol. 2018 Oct 8. 13 (10):1463-1470. [QxMD MEDLINE Link].
Kraut JA, Madias NE. Metabolic Acidosis of CKD: An Update. Am J Kidney Dis. 2015 Oct 15. [QxMD MEDLINE Link].
Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH. Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2013 May. 8(5):714-20. [QxMD MEDLINE Link]. [Full Text].
Witham MD, Lamb EJ. Should chronic metabolic acidosis be treated in older people with chronic kidney disease?. Nephrol Dial Transplant. 2016 Nov. 31 (11):1796-1802. [QxMD MEDLINE Link].
Goraya N, Wesson DE. Management of the Metabolic Acidosis of Chronic Kidney Disease. Adv Chronic Kidney Dis. 2017 Sep. 24 (5):298-304. [QxMD MEDLINE Link].
Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013 Mar. 8(3):371-81. [QxMD MEDLINE Link]. [Full Text].
Kraut JA, Madias NE. Lactic Acidosis: Current Treatments and Future Directions. Am J Kidney Dis. 2016 Sep. 68 (3):473-82. [QxMD MEDLINE Link].
Zakharov S, Pelclova D, Navratil T, Belacek J, Latta J, Pisar M, et al. Efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning. Clin Toxicol (Phila). 2016 Nov 7. 1-10. [QxMD MEDLINE Link].

Media Gallery

of 0

Author

Christie P Thomas, MBBS, FRCP, FASN, FAHA Professor, Department of Internal Medicine, Division of Nephrology, Departments of Pediatrics and Obstetrics and Gynecology, Medical Director, Kidney and Kidney/Pancreas Transplant Program, University of Iowa Hospitals and Clinics

Christie P Thomas, MBBS, FRCP, FASN, FAHA is a member of the following medical societies: American College of Physicians, American Heart Association, American Society of Nephrology, Royal College of Physicians

Disclosure: Nothing to disclose.

Coauthor(s)

Khaled Hamawi, MD, MHA Director, Multi Organ Transplant Center, King Fahad Specialist Hospital, Dammam

Khaled Hamawi, MD, MHA is a member of the following medical societies: American Society of Transplantation, American Society of Nephrology

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Eleanor Lederer, MD, FASN Professor of Medicine, Chief, Nephrology Division, Director, Nephrology Training Program, Director, Metabolic Stone Clinic, Kidney Disease Program, University of Louisville School of Medicine; Consulting Staff, Louisville Veterans Affairs Hospital

Eleanor Lederer, MD, FASN is a member of the following medical societies: American Association for the Advancement of Science, American Society for Bone and Mineral Research, American Society of Nephrology, American Society of Transplantation, International Society of Nephrology, Kentucky Medical Association, National Kidney Foundation

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: American Society of Nephrology<br/>Received income in an amount equal to or greater than $250 from: Healthcare Quality Strategies, Inc.

Chief Editor

Vecihi Batuman, MD, FASN Professor of Medicine, Section of Nephrology-Hypertension, Deming Department of Medicine, Tulane University School of Medicine

Vecihi Batuman, MD, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Additional Contributors

James W Lohr, MD Professor, Department of Internal Medicine, Division of Nephrology, Fellowship Program Director, University of Buffalo State University of New York School of Medicine and Biomedical Sciences

James W Lohr, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Society of Nephrology, Central Society for Clinical and Translational Research

Disclosure: Received research grant from: GSK<br/>Partner received salary from Alexion for employment.

Characteristics	Proximal (Type 2)	Distal (Type 1)	Type 4
Primary defect	Proximal HCO₃ - reabsorption	Diminished distal H+ secretion	Diminished ammoniagenesis
Urine pH	< 5.5 when serum HCO₃ - is low	>5.5	< 5.5
Serum HCO₃ -	>15 mEq/L	Can be < 10 mEq/L	>15 mEq/L
Fractional excretion of HCO₃ - (FEHCO₃)	>15-20% during HCO₃ - load	< 5% (can be as high as 10% in children)	< 5%
Serum K₊	Normal or mild decrease	Mild-to-severe decrease*	High
Associated features	Fanconi syndrome	...	Diabetes mellitus, renal insufficiency
Alkali therapy	High doses	Low doses	Low doses
Complications	Osteomalacia or rickets	Nephrocalcinosis, nephrolithiasis	...
*K⁺ may be high if RTA is due to volume depletion.

Metabolic Acidosis Questions & Answers

References

Tables

Contributor Information and Disclosures

What would you like to print?